News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
17
2025
-
02
Accurate implementation and efficient advancement! Linuo Pharmaceutical held a special meeting to deeply study and implement the spirit of the group meeting!
Classification：
News
行业新闻
Corporate News
2On the 15th of the month, Linuo Pharmaceutical held a special meeting to comprehensively convey and deeply study the spirit of the recent series of meetings of the Linuo Group. All middle-level and above management teams attended the meeting on-site, focusing on the group's core guidance of "strong execution, cost control, and efficiency improvement," concentrating on key topics such as indicator decomposition, management upgrades, and team self-drive, deeply analyzing development shortcomings, clarifying the path for tackling challenges, and promoting the comprehensive implementation of the group's spirit.
Confronting Problems: Solidifying Responsibilities with Goals
The meeting emphasized that all employees of Linuo Pharmaceutical should accurately grasp the company's annual operational indicators. From departments to individuals, goals must penetrate layer by layer, ensuring that "everyone bears indicators, and everyone takes responsibility!" All employees need to have a clear understanding of the company's core requirement of "profit orientation," being clear about their own goals and ensuring that the entire team understands "what to do, how to do it, and to what extent," eliminating vague goals and empty responsibilities.
Immediate Action: Launching Tough Initiatives
The meeting pointed out that in the future, the company will take action against "laid-back management," stating that cadres "will be reassigned if they do not bear indicators, and will be dismissed if they do not execute!" Managers at all levels must promote work with a "military order" mentality, focusing on profits, breaking down company indicators to departments, teams, and positions, signing responsibility agreements to achieve pressure transmission and benefit binding; vertically refining the production, research and development, and sales chain, and horizontally benchmarking against industry leaders; focusing on improving per capita labor efficiency, breaking through through automation upgrades and process optimization.
Overseas Layout: From Local Deep Cultivation to International Breakthrough
In the face of the challenge of increasing concentration in the domestic pharmaceutical market, Linuo Pharmaceutical has listed internationalization as a core strategy for its second growth curve. The company actively builds a quality control system in line with international standards, strengthens talent introduction and training, continuously expands overseas markets, and establishes a global marketing network to enhance its international competitiveness. By participating in international pharmaceutical exhibitions and strengthening communication and cooperation with overseas partners, Linuo Pharmaceutical is steadily moving towards a new stage of international development, striving to showcase the strength and style of Chinese pharmaceutical companies on a broader stage.
The meeting required all employees to seriously understand the meeting spirit, implement various decision deployments, and promote all work with a sense of urgency, ensuring a good start in the first month and the first quarter, and successfully completing all annual task objectives.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China